Systematic review and meta-analytic findings on the association between killer-cell immunoglobulin-like receptor genes and susceptibility to pulmonary tuberculosis

References

• Harding E. WHO global progress report on tuberculosis elimination. Lancet Respir Med. 2020;8(1):19.
   Google Scholar
• Nathavitharana RR, Friedland JS. A tale of two global emergencies: tuberculosis control efforts can learn from the ebola outbreak. Eur Respir J. 2015 Aug;46(2):293–296.
   Google Scholar
• WHO. WHO. Global tuberculosis report 2018; 2018 Sept 18 [cited 2019 Mar 11]. Available from: https://www.who.int/tb/publications/global_report/en/
   Google Scholar
• Hawn TR, Day TA, Scriba TJ, et al. Tuberculosis vaccines and prevention of infection. Microbiol Mol Biol Rev. 2014;78(4):650–671.
   Google Scholar
• Harris RE. Epidemiology of chronic disease: global perspectives. Jones & Bartlett Learning; 2019.
   Google Scholar
• Maeurer M, Schito M, Zumla A. Totally-drug-resistant tuberculosis: hype versus hope. Lancet Respir Med. 2014 Apr;2(4):256–257.
   Google Scholar
• D’Ambrosio L, Tadolini M, Centis R, et al. Supporting clinical management of the difficult-to-treat TB cases: the ERS-WHO TB consilium. Int J Infect Dis. 2015 Mar;32:156–160.
   Google Scholar
• Toossi Z. Virological and immunological impact of tuberculosis on human immunodeficiency virus type 1 disease. J Infect Dis. 2003 Oct 15;188(8):1146–1155.
   Google Scholar
• Havlir DV, Getahun H, Sanne I, et al. Opportunities and challenges for HIV care in overlapping HIV and TB epidemics. Jama. 2008 Jul 23;300(4):423–430.
   Google Scholar
• Allen M, Bailey C, Cahatol I, et al. Mechanisms of control of mycobacterium tuberculosis by NK cells: role of glutathione. Front Immunol. 2015;6:508.
   Google Scholar
• Voskoboinik I, Dunstone MA, Baran K, et al. Perforin: structure, function, and role in human immunopathology. Immunol Rev. 2010 May;235(1):35–54.
   Google Scholar
• Smyth MJ, Cretney E, Kelly JM, et al. Activation of NK cell cytotoxicity. Mol Immunol. 2005 Feb;42(4):501–510.
   Google Scholar
• Borrego F, Kabat J, Kim DK, et al. Structure and function of major histocompatibility complex (MHC) class I specific receptors expressed on human natural killer (NK) cells. Mol Immunol. 2002 Feb;38(9):637–660.
   Google Scholar
• Salim PH, Jobim M, Jobim LF, et al. Autoimmune rheumatic diseases and their association with killer immunoglobulin-like receptor genes. Rev Bras Reumatol Engl Ed. 2011 Jul-Aug;51(4):351–6, 362–4.
   Google Scholar
• Hsu KC, Chida S, Geraghty DE, et al. The killer cell immunoglobulin-like receptor (KIR) genomic region: gene-order, haplotypes and allelic polymorphism. Immunol Rev. 2002 Dec;190:40–52.
   Google Scholar
• Bashirova AA, Martin MP, McVicar DW, et al. The killer immunoglobulin-like receptor gene cluster: tuning the genome for defense. Annu Rev Genomics Hum Genet. 2006;7:277–300.
   Google Scholar
• Yawata M, Yawata N, Abi-Rached L, et al. Variation within the human killer cell immunoglobulin-like receptor (KIR) gene family. Crit Rev Immunol. 2002;22(5–6):463–482.
   Google Scholar
• Rajalingam R. Overview of the killer cell immunoglobulin-like receptor system. Methods Mol Biol. 2012;882:391–414.
   Google Scholar
• Tajik N, Shahsavar F, Mousavi T, et al. Distribution of KIR genes in the Iranian population. Tissue Antigens. 2009 Jul;74(1):22–31.
   Google Scholar
• Marsh SG, Parham P, Dupont B, et al. Killer-cell immunoglobulin-like receptor (KIR) nomenclature report, 2002. Tissue Antigens. 2003 Jul;62(1):79–86.
   Google Scholar
• McVicar DW, Taylor LS, Gosselin P, et al. DAP12-mediated signal transduction in natural killer cells. A dominant role for the Syk protein-tyrosine kinase. J Biol Chem. 1998 Dec 4;273(49):32934–32942.
   Google Scholar
• Williams AP, Bateman AR, Khakoo SI. Hanging in the balance. KIR and their role in disease. Mol Interv. 2005 Aug;5(4):226–240.
   Google Scholar
• Tajik N, Shah-hosseini A, Mohammadi A, et al. Susceptibility to pulmonary tuberculosis in Iranian individuals is not affected by compound KIR/HLA genotype. Tissue Antigens. 2012 Feb;79(2):90–96. DOI:10.1111/j.1399-0039.2011.01812.x
   Google Scholar
• Lu C, Shen YJ, Deng YF, et al. Association of killer cell immunoglobulin-like receptors with pulmonary tuberculosis in Chinese Han. Genet Mol Res: GMR. 2012 May 15;11(2):1370–1378.
   Google Scholar
• Salie M, Daya M, Moller M, et al. Activating KIRs alter susceptibility to pulmonary tuberculosis in a South African population. Tuberculosis (Edinb). 2015 Dec;95(6):817–821.
   Google Scholar
• Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med. 2009;6(7):e1000100.
   Google Scholar
• Huedo-Medina TB, Sánchez-Meca J, Marín-Martínez F, et al. Assessing heterogeneity in meta-analysis: Q statistic or I2 index? Psychol Methods. 2006;11(2):193.
   Google Scholar
• Egger M, Smith GD, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629–634.
   Google Scholar
• Mendez A, Granda H, Meenagh A, et al. Study of KIR genes in tuberculosis patients. Tissue Antigens. 2006 Nov;68(5):386–389.
   Google Scholar
• Mahfouz R, Halas H, Hoteit R, et al. Study of KIR genes in Lebanese patients with tuberculosis. Int J Tuberculosis Lung Dis. 2011 Dec;15(12):1688–1691.
   Google Scholar
• Lu C, Bai XL, Shen YJ, et al. Potential implication of activating killer cell immunoglobulin-like receptor and HLA in onset of pulmonary tuberculosis. Scand J Immunol. 2012 Nov;76(5):491–496.
   Google Scholar
• Shahsavar F, Mousavi T, Azargon A, et al. Association of KIR3DS1+HLA-B Bw4Ile80 combination with susceptibility to tuberculosis in Lur population of Iran. Iran J Immunol. 2012 Mar;9(1):39–47.
   Google Scholar
• Braun K, Larcombe L, Orr P, et al. Killer immunoglobulin-like receptor (KIR) centromeric-AA haplotype is associated with ethnicity and tuberculosis disease in a Canadian first nations cohort. PloS One. 2013;8(7):e67842.
   Google Scholar
• Pydi SS, Sunder SR, Venkatasubramanian S, et al. Killer cell immunoglobulin like receptor gene association with tuberculosis. Hum Immunol. 2013 Jan;74(1):85–92.
   Google Scholar
• Braun K, Wolfe J, Kiazyk S, et al. Evaluation of host genetics on outcome of tuberculosis infection due to differences in killer immunoglobulin-like receptor gene frequencies and haplotypes. BMC Genet. 2015 Jun;16(16):63.
   Google Scholar
• Hsu KC, Chida S, Geraghty DE, et al. The killer cell immunoglobulin‐like receptor (KIR) genomic region: gene‐order, haplotypes and allelic polymorphism. Immunol Rev. 2002;190(1):40–52.
   Google Scholar
• Middleton D, Gonzelez F. The extensive polymorphism of KIR genes. Immunology. 2010;129(1):8–19.
   Google Scholar
• Uhrberg M, Valiante NM, Shum BP, et al. Human diversity in killer cell inhibitory receptor genes. Immunity. 1997;7(6):753–763.
   Google Scholar
• Shilling HG, Guethlein LA, Cheng NW, et al. Allelic polymorphism synergizes with variable gene content to individualize human KIR genotype. J Immunol. 2002;168(5):2307–2315.
   Google Scholar
• Dhiman R, Indramohan M, Barnes PF, et al. IL-22 produced by human NK cells inhibits growth of Mycobacterium tuberculosis by enhancing phagolysosomal fusion. J Immunol. 2009;183(10):6639–6645.
   Google Scholar
• Vankayalapati R, Barnes PF. Innate and adaptive immune responses to human Mycobacterium tuberculosis infection. Tuberculosis. 2009;89:S77–S80.
   Google Scholar
• Vankayalapati R, Wizel B, Weis SE, et al. The NKp46 receptor contributes to NK cell lysis of mononuclear phagocytes infected with an intracellular bacterium. J Immunol. 2002;168(7):3451–3457.
   Google Scholar
• Vankayalapati R, Klucar P, Wizel B, et al. NK cells regulate CD8+ T cell effector function in response to an intracellular pathogen. J Immunol. 2004;172(1):130–137.
   Google Scholar
• Roy S, Barnes PF, Garg A, et al. NK cells lyse T regulatory cells that expand in response to an intracellular pathogen. J Immunol. 2008;180(3):1729–1736.
   Google Scholar
• Hsu KC, Liu X-R, Selvakumar A, et al. Killer Ig-like receptor haplotype analysis by gene content: evidence for genomic diversity with a minimum of six basic framework haplotypes, each with multiple subsets. J Immunol. 2002;169(9):5118–5129.
   Google Scholar
• Biassoni R, Pessino A, Malaspina A, et al. Role of amino acid position 70 in the binding affinity of p50. 1 and p58. 1 receptors for HLA‐Cw4 molecules. Eur J Immunol. 1997;27(12):3095–3099.
   Google Scholar
• Valés-Gómez M, Reyburn HT, Erskine RA, et al. Differential binding to HLA-C of p50-activating and p58-inhibitory natural killer cell receptors. Proc Nat Acad Sci. 1998;95(24):14326–14331.
   Google Scholar
• Vilches C, Rajalingam R, Uhrberg M, et al. KIR2DL5, a novel killer-cell receptor with a D0-D2 configuration of Ig-like domains. J Immunol. 2000;164(11):5797–5804.
   Google Scholar
• Hsu KC, Liu XR, Selvakumar A, et al. Killer Ig-like receptor haplotype analysis by gene content: evidence for genomic diversity with a minimum of six basic framework haplotypes, each with multiple subsets. J Immunol. 2002 Nov 1;169(9):5118–5129.
   Google Scholar
• Marsh SG, Parham P, Dupont B, et al. Killer-cell immunoglobulin-like receptor (KIR) nomenclature report, 2002. Immunogenetics. 2003;55(4):220–226.
   Google Scholar
• Zhuang Y, Song Y, Zhu C, et al. Association of KIR genotypes and haplotypes with syphilis in a Chinese Han population. Scand J Immunol. 2012;75(3):361–367.
   Google Scholar
• Traherne JA, Jiang W, Valdes AM, et al. KIR haplotypes are associated with late-onset type 1 diabetes in European–American families. Genes Immun. 2016;17(1):8.
   Google Scholar
• Martin MP, Gao X, Lee J-H, et al. Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS. Nat Genet. 2002;31(4):429.
   Google Scholar
• Aghaei H, Mostafaei S, Aslani S, et al. Association study between KIR polymorphisms and rheumatoid arthritis disease: an updated meta-analysis. BMC Med Genet. 2019;20(1):24.
   Google Scholar
• Fathollahi A, Aslani S, Mostafaei S, et al. The role of killer-cell immunoglobulin-like receptor (KIR) genes in susceptibility to inflammatory bowel disease: systematic review and meta-analysis. Inflammation Res. 2018;67(9):727–736.
   Google Scholar
• Rezaei R, Mostafaei S, Aslani S, et al. Association study between killer immunoglobulin‐like receptor polymorphisms and ankylosing spondylitis disease: an updated meta‐analysis. Int J Rheum Dis. 2018;21(10):1746–1755.
   Google Scholar
• Tajik N, Shah‐Hosseini A, Mohammadi A, et al. Susceptibility to pulmonary tuberculosis in Iranian individuals is not affected by compound KIR/HLA genotype. Tissue Antigens. 2012;79(2):90–96.
   Google Scholar